Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by prophetoffactzon Feb 07, 2023 10:22am
164 Views
Post# 35271643

RE:Typical results

RE:Typical resultsGiven the slow first half that is expected for Groome to even mention $30 million in annual revenue as he did suggests how explosive the second half could be. Think of the potential year-end run-rate. Given that we are already over 1 month into Q2 and the need for planning and orders to be placed in advance of a potentially explosive second half there should be significant visibility going into the second half. Add in a potential Kinlytic deal and get ready! The company continues buying back shares.

RazeKreations wrote: 86000 shares traded today so far.  What a joke.  It is going to be a long wait for any substantial movement for this stock.  first quarter was a dud and second will be no better as per Cameron's comment about expecting some poor results first half of year. That brings us up to this fall before any good quarterly results are posted.  One can only hope something turns around like a major contract, but past results are making it hard to still be a believer. Still hanging on but my fingers are getting tired


<< Previous
Bullboard Posts
Next >>